Financial Performance Summary - Q2 FY2025 sales for continuing operations increased by 1367 billion yen, a 5% increase year-on-year[8, 10] - Operating income for Q2 FY2025 increased by 396 billion yen, a 10% increase year-on-year[8, 10] - Net income attributable to Sony Group Corporation's stockholders increased by 197 billion yen, a 7% increase year-on-year[8] - FY2025 sales forecast revised upward by 300 billion yen, a 3% increase from the August forecast[12, 13] - FY2025 operating income forecast revised upward by 100 billion yen, an 8% increase from the August forecast[12, 13] Segment Performance - Game & Network Services (G&NS) sales increased by 416 billion yen, a 4% increase year-on-year, but operating income decreased by 185 billion yen, a 13% decrease[11, 21] - Music segment sales increased by 942 billion yen, a 21% increase year-on-year, and operating income increased by 250 billion yen, a 28% increase[11, 25] - Imaging & Sensing Solutions (I&SS) sales increased by 791 billion yen, a 15% increase year-on-year, and operating income increased by 459 billion yen, a 50% increase[11, 44] - Entertainment, Technology & Services (ET&S) sales decreased by 440 billion yen, a 7% decrease year-on-year, and operating income decreased by 92 billion yen, a 13% decrease[11, 36] Strategic Changes - Sony executed a partial spin-off of Sony Financial Group Inc (SFGI) effective October 1, 2025, classifying the Financial Services business as a discontinued operation[7] - From Q3 FY25, Sony will apply the equity method to SFGI shares and record profit or loss from SFGI shares as operating income in continuing operations[7]

Financial Performance & Investment Highlights - K+S Group's revenues for 9M/2025 were €2,715.0 million[11] - Adjusted free cash flow for 9M/2025 was €61.6 million[11] - EBITDA for 9M/2025 was €421.0 million, with an EBITDA margin of 15.5%[11] - K+S aims for an EBITDA margin of >20% over a 5-year cycle[70] - K+S generally strives for a maximum leverage ratio (net debt/EBITDA) of 1.5x[70] Market Position & Growth - K+S expects potash demand to grow at a compound annual growth rate of 2-3%[14] - K+S aims to increase potash production in Bethune, Canada from 2 million tonnes to 4 million tonnes per year[12, 76] - Agriculture segment revenues for 9M/2025 were €1,897.6 million with sales volumes of 5.63 million tonnes[20] - Industry+ segment revenues for 9M/2025 were €817.4 million with sales volumes of 4.66 million tonnes[22] - K+S has a 20% market share in the European salt market[64] Sustainability & Environmental Goals - K+S has reduced CO2 emissions by around 80% since 1990[17] - K+S aims to achieve greenhouse gas neutrality at its production sites by 2045[17] - K+S aims for a 25% CO2 emissions reduction by 2030 and 60% by 2040[77, 104] - K+S wants to cover a further 155 hectares of tailings pile area by 2030[225]

This presentation contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include descriptions regarding the intent, belief or current expectations of the Company or its officers about the future. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those in th ...

Pipeline Highlights - Varegacestat, an oral gamma secretase inhibitor for desmoid tumors, expects Phase 3 topline data before the end of 2025[9] - IM-1021, a ROR1 ADC, has shown objective responses in B-cell lymphoma patients at multiple dose levels[9] - IM-3050, a FAP radiotherapy, anticipates Phase 1 initiation in early 2026[9] - Three novel ADCs against solid tumor targets are undergoing IND-enabling studies to support 2026 INDs[9] HC74 Payload - HC74, a proprietary TOP1i ADC payload, is considered to have best-in-class potential[9] - HC74 demonstrates a lower efflux ratio of 10 compared to DXd's 79, potentially overcoming chemo-resistance[69] - HC74 ADC shows a payload loss of 18% at Day 7, compared to 36% for DXd ADC, indicating enhanced stability[75] Financial and Leadership - The company's cash runway is expected to extend into 2027[9] - The company's leadership team includes executives with experience at Seagen, where they grew revenue to over $2 billion in 2022, leading to a $43 billion acquisition[14] Varegacestat Market Potential - The estimated revenue for gamma secretase inhibitors (GSIs) in the US desmoid patient market is $356 million in 2025[20] - Phase 2 RINGSIDE Part A data showed a 64% response rate in the 1.2mg QD arm (n=14) and 55% overall (n=42)[27]

Q3'25 Financial Performance - Life360's Q3'25 revenue reached $124.5 million, a 34% year-over-year increase[19, 125] - Adjusted EBITDA for Q3'25 was $24.5 million, representing a 20% margin[19, 125] - Global Paying Circles grew to approximately 2.7 million, a 23% year-over-year increase[19, 125] - Annualized Monthly Revenue (AMR) increased by 33% to $446.7 million[126] User Engagement and Growth - Global Monthly Active Users (MAU) reached approximately 91.6 million, a 19% year-over-year increase[19, 125] - International MAU experienced a 24% year-over-year growth[125] - Life360 is ranked as the 7 top social networking app by DAU in the U S[19] Revenue Breakdown - Subscription revenue was $96.3 million, a 34% year-over-year increase[126] - Hardware revenue was $11.3 million, a 4% year-over-year decrease[126] - Other revenue, including data and partnership agreements, was $16.9 million, an 82% year-over-year increase[126] FY'25 Outlook - Life360 expects consolidated revenue of $474 million to $485 million for FY'25[169] - The company anticipates positive Adjusted EBITDA of $84 million to $88 million for FY'25[168]

NYSE: DHX Q3 2025 Investor Presentation November 10, 2025 Forward looking statements This presenation and oral statements made from time to time by our representatives contain forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You should not place undue reliance on those statements because they are subject to numerous uncertainties an ...

SAFE HARBOR This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as "guidance," "believe," "expect," "estimate," "project," "plan," "will," or words or phrases with similar meaning. Forward-looking statements s ...

03-2025 INFESTOR UPDATE Sir Peter Beck, CEO Adam Spice, CFO November 10, 2025 ROCKETLAB Forward Looking Statements This presentation may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our expec ...

Financial Performance - The RealReal achieved a record quarterly GMV of $520 million, a 20% year-over-year increase[20, 24] - Revenue reached $174 million, up 17% year-over-year, with Consignment Revenue increasing by 15% and Direct Revenue by 47%[29] - Adjusted EBITDA was $9.3 million, representing 5.4% of Total Revenue, a 380 basis points year-over-year increase[20, 31] - The company generated $14 million in Free Cash Flow[20] Operational Efficiency and Scalability - Athena, the company's AI-enabled product intake process, scaled to approximately 27% of all units and is on track for 30-40% by year-end[20] - Consignment Gross Margin increased by 70 basis points year-over-year to 89.3%[20] - Operating Expenses improved by 620 basis points year-over-year as a percentage of revenue due to operating efficiencies, AI and automation, and fixed cost leverage[20, 34] Customer Engagement - Active Buyers reached an all-time high of 1.024 million, a 7% increase on a trailing 12-month basis[20, 26] - Supply value per existing Luxury Manager increased by 12% year-over-year, driven by a new compensation plan and AI investments[20] - Over 80% of GMV comes from repeat customers[44] Outlook - The company raised its Full-Year 2025 Guidance[20] - The FY25 Adjusted EBITDA outlook reflects approximately 400 basis points margin expansion versus 2024 at the guidance midpoint[20] - Full year GMV is projected to be between $2.099 billion and $2.109 billion[36] - Full year Revenue is projected to be between $687 million and $690 million[36] - Full year Adjusted EBITDA is projected to be between $37.7 million and $38.7 million[36]

Exhibit 99.2 Q3 2025 Earnings Supplement November 2025 Disclaimer 1 Repay Holdings Corporation ("REPAY" or the "Company") is required to file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission ("SEC") Such filings, which you may obtain for free at the SEC's website at http://www.sec.gov, discuss some of the important risk factors that may affect REPAY's business, results of operations and financial condition. Forward-Looking Statements T ...